Therapeutic polypeptides, nucleic acids encoding same, and methods of use
CA 2448540 A1 · Owner: Edinger, Shlomit R. · Inventors: Casman, Stacie J.; Shenoy, Suresh G.; Guo, Xiaojia
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to novel polypeptides and the nucleic acids , encoding them, having properties related to stimulation of biochemical or physiological responses in a cell, a tissue an organ or an organism. More , particularly the novel polypeptides are gene products of novel genes or are , specified biologically active fragments or derivatives thereof. Methods of use encompass diagnostic and prognostic assay procedures as well as methods of treating diverse pathological conditions.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 3, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 3, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 3, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.